-
1
-
-
0344373794
-
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
ALLHAT Collaborative Research Group
-
ALLHAT Collaborative Research Group. 2002. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA, 288:2981-97.
-
(2002)
JAMA
, vol.288
, pp. 2981-2997
-
-
-
2
-
-
23944472238
-
Treatment of hypertension in adults with diabetes
-
American Diabetes Association
-
American Diabetes Association. 2002. Treatment of hypertension in adults with diabetes. Diabetes Care, 25:199-201.
-
(2002)
Diabetes Care
, vol.25
, pp. 199-201
-
-
-
3
-
-
0035842331
-
A practical approach to achieving recommended blood pressure goals in diabetic patients
-
Bakris GL. 2001. A practical approach to achieving recommended blood pressure goals in diabetic patients. Arch Intern Med, 161:2661-7.
-
(2001)
Arch Intern Med
, vol.161
, pp. 2661-2667
-
-
Bakris, G.L.1
-
4
-
-
0037720962
-
A comparison of observational studies and randomized, controlled trials
-
Benson & Hartz AJ. 2000. A comparison of observational studies and randomized, controlled trials. Am J Ophthalmol, 130:688.
-
(2000)
Am J Ophthalmol
, vol.130
, pp. 688
-
-
Benson1
Hartz, A.J.2
-
5
-
-
4143125777
-
Incremental effectiveness of amlodipine besylate in the treatment of hypertension with single and multiple medication regimens
-
Bisognano J, McLaughlin T, Roberts CS, et al. 2004. Incremental effectiveness of amlodipine besylate in the treatment of hypertension with single and multiple medication regimens. Am J Hypertens, 17:676-83.
-
(2004)
Am J Hypertens
, vol.17
, pp. 676-683
-
-
Bisognano, J.1
McLaughlin, T.2
Roberts, C.S.3
-
6
-
-
0037851836
-
Principal results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial
-
Black HR, Elliott WJ, Grandits G, et al. 2003. Principal results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial. JAMA, 289:2073-82.
-
(2003)
JAMA
, vol.289
, pp. 2073-2082
-
-
Black, H.R.1
Elliott, W.J.2
Grandits, G.3
-
7
-
-
0035144723
-
Electronic compliance monitoring in resistant hypertension: The basis for rational therapeutic decisions
-
Burnier M, Schneider MP, Chiolero A, et al. 2001. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens, 19:335-41.
-
(2001)
J Hypertens
, vol.19
, pp. 335-341
-
-
Burnier, M.1
Schneider, M.P.2
Chiolero, A.3
-
8
-
-
0023092594
-
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
-
Charlson ME, Pompei P, Ales KL, et al. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis, 40:373-83.
-
(1987)
J Chronic Dis
, vol.40
, pp. 373-383
-
-
Charlson, M.E.1
Pompei, P.2
Ales, K.L.3
-
9
-
-
0347423198
-
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
-
Chobanian AV, Bakris GL, Black HR, et al. 2003. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 42:1206-52.
-
(2003)
Hypertension
, vol.42
, pp. 1206-1252
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
-
10
-
-
0034702175
-
Randomized, controlled trials, observational studies, and the hierarchy of research designs
-
Concato J, Shah N, Horwitz RI. 2000. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med, 342:1887-92.
-
(2000)
N Engl J Med
, vol.342
, pp. 1887-1892
-
-
Concato, J.1
Shah, N.2
Horwitz, R.I.3
-
11
-
-
3543135271
-
Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
-
D'Agostino RB Jr. 1998. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med, 17:2265-81.
-
(1998)
Stat Med
, vol.17
, pp. 2265-2281
-
-
D'Agostino Jr., R.B.1
-
12
-
-
0037160968
-
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
-
Dahlöf B, Devereux RB, Kjeldsen SE, et al. 2002. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet, 359:995-1003.
-
(2002)
Lancet
, vol.359
, pp. 995-1003
-
-
Dahlöf, B.1
Devereux, R.B.2
Kjeldsen, S.E.3
-
13
-
-
24644443331
-
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial
-
Dahlöf B, Sever PS, Poulter NR, et al. 2005. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet, 366:895-906.
-
(2005)
Lancet
, vol.366
, pp. 895-906
-
-
Dahlöf, B.1
Sever, P.S.2
Poulter, N.R.3
-
14
-
-
0037527647
-
European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension
-
Guidelines Committee
-
Guidelines Committee. 2003. European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens, 21:1011-53.
-
(2003)
J Hypertens
, vol.21
, pp. 1011-1053
-
-
-
15
-
-
0038690424
-
Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000
-
Hajjar I, Kotchen TA. 2003. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA, 290:199-206.
-
(2003)
JAMA
, vol.290
, pp. 199-206
-
-
Hajjar, I.1
Kotchen, T.A.2
-
16
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group
-
Hansson L, Zanchetti A, Carruthers SG, et al. 1998. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet, 351:1755-62.
-
(1998)
Lancet
, vol.351
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
Carruthers, S.G.3
-
17
-
-
0034181905
-
Clinical Advisory Statement. Importance of systolic blood pressure in older Americans
-
Izzo JL Jr, Levy D, Black HR. 2000. Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension, 35:1021-4.
-
(2000)
Hypertension
, vol.35
, pp. 1021-1024
-
-
Izzo Jr, J.L.1
Levy, D.2
Black, H.R.3
-
18
-
-
0030713021
-
-
Joint National Committee on, Detection, Evaluation, and Treatment of High Blood Pressure. 1997. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med, 157:2413-46.
-
Joint National Committee on, Detection, Evaluation, and Treatment of High Blood Pressure. 1997. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med, 157:2413-46.
-
-
-
-
19
-
-
2942635317
-
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial
-
Julius S, Kjeldsen SE, Weber M, et al. 2004. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet, 363:2022-31.
-
(2004)
Lancet
, vol.363
, pp. 2022-2031
-
-
Julius, S.1
Kjeldsen, S.E.2
Weber, M.3
-
20
-
-
0035922447
-
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
-
Lewis EJ, Hunsicker LG, Clarke WR, et al. 2001. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med, 345:851-60.
-
(2001)
N Engl J Med
, vol.345
, pp. 851-860
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Clarke, W.R.3
-
21
-
-
0027461577
-
Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents
-
Materson BJ, Reda DJ, Cushman WC, et al. 1993. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med, 328:914-21.
-
(1993)
N Engl J Med
, vol.328
, pp. 914-921
-
-
Materson, B.J.1
Reda, D.J.2
Cushman, W.C.3
-
22
-
-
0030806211
-
The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: Results from a population-based study in the elderly
-
Monane M, Bohn RL, Gurwitz JH, et al. 1997. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens, 10:697-704.
-
(1997)
Am J Hypertens
, vol.10
, pp. 697-704
-
-
Monane, M.1
Bohn, R.L.2
Gurwitz, J.H.3
-
23
-
-
0025805153
-
Channeling bias in the interpretation of drug effects
-
Petri H, Urquhart J. 1991. Channeling bias in the interpretation of drug effects. Stat Med, 10:577-81.
-
(1991)
Stat Med
, vol.10
, pp. 577-581
-
-
Petri, H.1
Urquhart, J.2
-
24
-
-
0027445675
-
Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives
-
Romano PS, Roos LL, Jollis JG. 1993. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol, 46:1075-97.
-
(1993)
J Clin Epidemiol
, vol.46
, pp. 1075-1097
-
-
Romano, P.S.1
Roos, L.L.2
Jollis, J.G.3
-
25
-
-
0038203004
-
Cardiovascular prevention and blood pressure reduction: A quantitative overview updated until 1 March 2003
-
Staessen JA, Wang JG, Thijs L. 2003. Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens, 21:1055-76.
-
(2003)
J Hypertens
, vol.21
, pp. 1055-1076
-
-
Staessen, J.A.1
Wang, J.G.2
Thijs, L.3
-
26
-
-
22144477948
-
Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: Results ofprospectively designed overviews of randomized trials
-
Turnbull F, Neal B, Algert C, et al. 2005. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results ofprospectively designed overviews of randomized trials. Arch Intern Med, 165:1410-19.
-
(2005)
Arch Intern Med
, vol.165
, pp. 1410-1419
-
-
Turnbull, F.1
Neal, B.2
Algert, C.3
|